10X Genomics Inc Free Cash Flow Generation Index

Latest as of June 2026: 0.91x

10X Genomics Inc free cash flow generation index. 10X Genomics Inc (TXG) has a Free Cash Flow Generation Index of 0.91x as of June 2026. Free cash flow of $15.39 Million represents 1% of operating cash flow ($16.97 Million).

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

$15.39 Million
USD

Operating Cash Flow

$16.97 Million
USD

Capital Expenditures

$1.59 Million
USD

Free Cash Flow Generation Index of 10X Genomics Inc (2019–2025)

Free cash flow generation index of 10X Genomics Inc from 2019 to 2025. Historical FCF Generation Index trend for 10X Genomics Inc across 3 annual periods. See TXG financial flexibility score to measure the company's free cash flow as a share of total liabilities.

10X Genomics Inc Free Cash Flow Generation Index by Year (2019–2025)

10X Genomics Inc free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for 10X Genomics Inc. For the full cash flow conversion analysis, see TXG cash generation efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.96x $130.12 Million $136.05 Million $5.93 Million ▲ +211.2%
2024 -0.86x $-5.73 Million $6.66 Million $12.39 Million ▼ -265.7%
2019 -0.24x $-8.14 Million $34.63 Million $42.77 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).